{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T06:42:34Z","timestamp":1792737754328,"version":"4.5.0"},"reference-count":32,"publisher":"BMJ","issue":"1","license":[{"start":{"date-parts":[[2021,2,5]],"date-time":"2021-02-05T00:00:00Z","timestamp":1612483200000},"content-version":"unspecified","delay-in-days":4,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["Open Heart"],"accepted":{"date-parts":[[2020,12,21]]},"published-print":{"date-parts":[[2021,2]]},"abstract":"<jats:sec>\n                  <jats:title>Objective<\/jats:title>\n                  <jats:p>To identify factors associated with hypertension control among treated middle-aged UK adults.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>A cross-sectional population-based study including 99 468 previously diagnosed, treated hypertensives enrolled in the UK Biobank. Hypertension control was defined as systolic blood pressure &lt;140 mm Hg and diastolic blood pressure &lt;90 mm Hg.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>Median age was 62.3 years (IQR 57.3 to 66.0), 45.9% female, 92.0% white, 40.1% obese, 9.3% current smokers and 19.4% had prior cardiovascular disease. 38.1% (95% CI 37.8% to 38.4%) were controlled. In multivariable logistic regression, associations with lack of hypertension control included: older age (OR 0.61, 95% CI 0.58 to 0.64 for 60\u201369 years compared with age 40\u201350 years), higher alcohol use (OR 0.61, 95% CI 0.58 to 0.64, for consuming &gt;30 units per week compared with none), black ethnicity (OR 0.73, 95% CI 0.65 to 0.82 compared with white), obesity (OR 0.73, 95% CI 0.71 to 0.76 compared with normal body mass index). The strongest positive association with control was having \u22653 comorbidities (OR 2.09, 95% CI 1.95 to 2.23). Comorbidities associated with control included cardiovascular disease (OR 2.11, 95% CI 2.04 to 2.19), migraines (OR 1.68, 95% CI 1.56 to 1.81), diabetes (OR 1.32, 95% CI 1.27 to 1.36) and depression (OR 1.27, 95% CI 1.20 to 1.34).<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusions<\/jats:title>\n                  <jats:p>In one of the largest population-based analyses of middle-aged adults with measured blood pressure, the majority of treated hypertensives were uncontrolled. Risk factors for hypertension were associated with a lower probability of control. Having a comorbidity was associated with higher probability of control, possibly due to more frequent interaction with the healthcare system and\/or appropriate management of those at greater cardiovascular risk.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1136\/openhrt-2020-001461","type":"journal-article","created":{"date-parts":[[2021,3,11]],"date-time":"2021-03-11T20:00:30Z","timestamp":1615492830000},"page":"e001461","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":82,"title":["Prevalence and determinants of hypertension control among almost 100 000 treated adults in the UK"],"prefix":"10.1136","volume":"8","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2048-3973","authenticated-orcid":false,"given":"Neo","family":"Tapela","sequence":"first","affiliation":[{"name":"Nuffield Department of Population Health, University of Oxford, Oxford, Oxfordshire, UK"},{"name":"Botswana-Harvard AIDS Institute Partnership, Gaborone, Botswana"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer","family":"Collister","sequence":"additional","affiliation":[{"name":"Nuffield Department of Population Health, University of Oxford, Oxford, Oxfordshire, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Clifton","sequence":"additional","affiliation":[{"name":"Nuffield Department of Population Health, University of Oxford, Oxford, Oxfordshire, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iain","family":"Turnbull","sequence":"additional","affiliation":[{"name":"Nuffield Department of Population Health, University of Oxford, Oxford, Oxfordshire, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazem","family":"Rahimi","sequence":"additional","affiliation":[{"name":"Deep Medicine, Nuffield Department of Reproductive and Women\u2019s Health, University of Oxford, Oxford, Oxfordshire, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David J","family":"Hunter","sequence":"additional","affiliation":[{"name":"Nuffield Department of Population Health, University of Oxford, Oxford, Oxfordshire, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2021,3,11]]},"reference":[{"key":"2025081612042250000_8.1.e001461.1","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1038\/s41581-019-0244-2","article-title":"The global epidemiology of hypertension","volume":"16","author":"Mills","year":"2020","journal-title":"Nat Rev Nephrol"},{"key":"2025081612042250000_8.1.e001461.2","unstructured":"World Health Organization . A global brief on hypertension: silent killer, global public health crisis. WHO global brief: Geneva, Switzerland, 2013."},{"key":"2025081612042250000_8.1.e001461.3","doi-asserted-by":"publisher","DOI":"10.1161\/01.HYP.0000107251.49515.c2"},{"key":"2025081612042250000_8.1.e001461.4","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(15)01225-8"},{"key":"2025081612042250000_8.1.e001461.5","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2013.184182"},{"key":"2025081612042250000_8.1.e001461.6","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2020\/8082341","article-title":"Prevalence and determinants of hypertension awareness, treatment, and control in Botswana: a nationally representative population-based survey","volume":"2020","author":"Tapela","year":"2020","journal-title":"Int J Hypertens"},{"key":"2025081612042250000_8.1.e001461.7","doi-asserted-by":"publisher","DOI":"10.1186\/s12875-015-0313-y"},{"key":"2025081612042250000_8.1.e001461.8","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.113.007699"},{"key":"2025081612042250000_8.1.e001461.9","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2010.650"},{"key":"2025081612042250000_8.1.e001461.10","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(12)60240-2"},{"key":"2025081612042250000_8.1.e001461.11","doi-asserted-by":"publisher","DOI":"10.3399\/bjgp18X695465"},{"key":"2025081612042250000_8.1.e001461.12","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1016\/j.mayocp.2018.02.012","article-title":"Patterns of multimorbidity in middle-aged and older adults: an analysis of the UK Biobank data","volume":"93","author":"Zemedikun","year":"2018","journal-title":"Mayo Clin Proc"},{"key":"2025081612042250000_8.1.e001461.13","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.112.004531","article-title":"Multimorbidity and blood pressure control in 37 651 hypertensive","volume":"2","author":"Paulsen","year":"2012","journal-title":"J Am Hear Assoc"},{"key":"2025081612042250000_8.1.e001461.14","doi-asserted-by":"publisher","DOI":"10.1093\/aje\/kwx246"},{"key":"2025081612042250000_8.1.e001461.15","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(16)31919-5"},{"key":"2025081612042250000_8.1.e001461.16","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.0000154900.76284.F6"},{"key":"2025081612042250000_8.1.e001461.17","unstructured":"World Health Organisation . Introduction to drug utilization research. Geneva, Switzerland, 2003."},{"key":"2025081612042250000_8.1.e001461.18","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2016-012177"},{"key":"2025081612042250000_8.1.e001461.19","doi-asserted-by":"publisher","DOI":"10.1249\/01.MSS.0000078924.61453.FB"},{"key":"2025081612042250000_8.1.e001461.20","unstructured":"Yousaf S , Bonsall A . Uk Townsend deprivation scores from 2011 census data. UK Data Service, 2017."},{"key":"2025081612042250000_8.1.e001461.21","doi-asserted-by":"crossref","first-page":"e1002513","DOI":"10.1371\/journal.pmed.1002513","article-title":"Patterns and temporal trends of comorbidity among adult patients with incident cardiovascular disease in the UK between 2000 and 2014: a population-based cohort study","volume":"15","author":"Tran","year":"2018","journal-title":"PLoS Med"},{"key":"2025081612042250000_8.1.e001461.22","unstructured":"R foundation for statistical computing . A language and environment for statistical computing. Vienna, Austria: R foundation for statistical computing, 2019. www.R-project ORG"},{"key":"2025081612042250000_8.1.e001461.23","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.115.018912"},{"key":"2025081612042250000_8.1.e001461.24","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1016\/S0140-6736(19)31145-6","article-title":"Long-term and recent trends in hypertension awareness, treatment, and control in 12 high-income countries: an analysis of 123 nationally representative surveys","volume":"394","year":"2019","journal-title":"Lancet"},{"key":"2025081612042250000_8.1.e001461.25","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1093\/ajh\/hpx138","article-title":"Clinical outcomes by race and ethnicity in the systolic blood pressure intervention trial (sprint): a randomized clinical trial","volume":"31","author":"Still","year":"2018","journal-title":"Am J Hypertens"},{"key":"2025081612042250000_8.1.e001461.26","unstructured":"NHS . Revisions to the GMS contract 2006 \/ 07 delivering investment in general practice 2006."},{"key":"2025081612042250000_8.1.e001461.27","doi-asserted-by":"publisher","DOI":"10.3399\/bjgp11X572454"},{"key":"2025081612042250000_8.1.e001461.28","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1161\/01.HYP.0000218586.21932.3c","article-title":"Alcohol and hypertension: an update","volume":"47","author":"Beilin","year":"2006","journal-title":"Hypertension"},{"key":"2025081612042250000_8.1.e001461.29","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1093\/ajh\/hpy047","article-title":"Factors associated with hypertension control in US adults using 2017 ACC\/AHA guidelines: National health and nutrition examination survey 1999-2016","volume":"31","author":"Ostchega","year":"2018","journal-title":"Am J Hypertens"},{"key":"2025081612042250000_8.1.e001461.30","doi-asserted-by":"publisher","DOI":"10.1161\/CIR.0000000000000534"},{"key":"2025081612042250000_8.1.e001461.31","unstructured":"Shahu A , Herrin J , Dhruva SS . Disparities in socioeconomic context and association with blood. JAHA 2019."},{"key":"2025081612042250000_8.1.e001461.32","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijid.2020.03.017"}],"container-title":["Open Heart"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/openhrt-2020-001461","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,16]],"date-time":"2025-08-16T19:04:37Z","timestamp":1755371077000},"score":1,"resource":{"primary":{"URL":"https:\/\/openheart.bmj.com\/lookup\/doi\/10.1136\/openhrt-2020-001461"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,2]]},"references-count":32,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2021,3,11]]},"published-print":{"date-parts":[[2021,2]]}},"alternative-id":["10.1136\/openhrt-2020-001461"],"URL":"https:\/\/doi.org\/10.1136\/openhrt-2020-001461","relation":{},"ISSN":["2053-3624"],"issn-type":[{"value":"2053-3624","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,2]]}}}